4//SEC Filing
Williamson Robert F III 4
Accession 0000950170-25-048698
CIK 0000728387other
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 5:04 PM ET
Size
7.3 KB
Accession
0000950170-25-048698
Insider Transaction Report
Form 4
Williamson Robert F III
Director
Transactions
- Purchase
Common Stock
2025-03-28$2.27/sh+22,192$50,376→ 70,837 total - Purchase
Common Stock
2025-03-31$2.14/sh+38,145$81,775→ 108,982 total
Holdings
- 366(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.12 to $2.1697, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price in the transaction described in this footnote.
Documents
Issuer
Perspective Therapeutics, Inc.
CIK 0000728387
Entity typeother
Related Parties
1- filerCIK 0001397331
Filing Metadata
- Form type
- 4
- Filed
- Mar 31, 8:00 PM ET
- Accepted
- Apr 1, 5:04 PM ET
- Size
- 7.3 KB